Science Industry Partnership

SIP 2030 Skills Strategy

As part of the Life Sciences Industrial Strategy and Sector Deal, the Science Industry Partnership (SIP) has been commissioned to deliver a skills strategy report for the Life Sciences sector. This report will underpin the skills needs of the industry through to 2030, building a clear and robust evidence base of the current workforce to provide a forward-looking strategy.

The Life Sciences 2030 Skills Strategy will be an employer-led piece of work produced by the  SIP Futures Group – a collaboration between SIP employers, Office for Life Sciences (OLS), Association of the British Pharmaceutical Industry (ABPI) and BioIndustry Association (BIA).

The Strategy will build a clear evidence base of the status of life science skills and future scenarios to 2030, focusing on medicines manufacturing for established medicines and advanced therapies (supported by the Medicines Manufacturing Industry Partnership) as well as other emerging technologies, such as Artificial Intelligence (AI), to identify what is needed in addition to current available training provision.

The Skills Strategy 2030 will deliver the Blueprint for the People Pillar of the Life Sciences Sector Deal, driving productivity and promoting confidence in doing business in the UK.

The proposed Skills Strategy will set out to build a clear evidence base with a focus on:

  • An assessment and identification of the new skills demand for research and development activities
  • Further analysis on the new skills needed for medicines manufacturing for established medicines and complex medicines
  • A review of vocational skills training delivery, including a gap analysis vs the training provision base
  • A study of post Brexit UK workforce skills capacity and needs.

Alex Felthouse, SIP Board member who is leading on the 2030 Strategy development, and Managing Director of Eisai Manufacturing Ltd said:

“The UK Life Sciences sector continues to make advances in science and technology which improve all our lives, making new discoveries that deliver treatments once unimaginable.   It has an ongoing need to recruit, train and develop employees and its demand for higher-level skills continues to intensify. This important Strategy will ensure we focus our efforts on emerging and growing skills shortages, providing us with clear priority areas that we can target with both action and solutions, in partnership with Government.

“It will also support us to develop a Post-Brexit skills policy to identify provision gaps that are resulting in the need to look from outside of the UK for the science skills essential for growth. This approach needs to be responsive and based on employer demand, rather than the current and expedient shortage arrangements. Industry needs access to essential skills not always available in the UK; maintaining expertise and scientific knowledge in innovation and research will be key in the future.”

In the official Government Press Release, Business Secretary Greg Clark said:

“From the first vaccine to the discovery of DNA, the UK has always been at the forefront of medical endeavour and healthcare innovations. That is why we are building on our unique strengths by placing life sciences at the centre of our modern Industrial Strategy, backed by the biggest increase in public research and development investment in UK history.

“This is our modern Industrial Strategy in action as we work hand in hand with industry to ensure the UK remains the go-to destination for launching new businesses, new discoveries and treatments to benefit health around the world.

“The announcement of UCB’s investment in new research and development is a clear vote of confidence in UK life sciences research base and business.”

Download Government Press Release

Download Government Fact Sheet

Showcase